These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 31635993

  • 1. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, Boulos C, Ibrahim G, Yousef GM.
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM.
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y, Guan B, Liu J, Zhang Z, He S, Zhan Y, Su B, Han H, Zhang X, Wang B, Li X, Zhou L, Zhao W.
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [Abstract] [Full Text] [Related]

  • 4. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P, Dasgupta P, Hashimoto Y, Shiina M, Shahryari V, Tabatabai ZL, Yamamura S, Tanaka Y, Saini S, Dahiya R, Majid S.
    Cancer Res; 2021 Mar 15; 81(6):1500-1512. PubMed ID: 33500248
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma.
    Lyu J, Zhu Y, Zhang Q.
    Cancer Biomark; 2020 Mar 15; 28(2):141-149. PubMed ID: 32116235
    [Abstract] [Full Text] [Related]

  • 7. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A.
    PLoS One; 2016 Mar 15; 11(6):e0157801. PubMed ID: 27336447
    [Abstract] [Full Text] [Related]

  • 8. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
    Maolakuerban N, Azhati B, Tusong H, Abula A, Yasheng A, Xireyazidan A.
    Cancer Biol Ther; 2018 Apr 03; 19(4):282-291. PubMed ID: 29394133
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG, Tolkach Y, Deng M, Schmidt D, Perner S, Kristiansen G, Müller SC, Ellinger J.
    Clin Epigenetics; 2018 Apr 03; 10():11. PubMed ID: 29410711
    [Abstract] [Full Text] [Related]

  • 10. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H, Enokida H, Itesako T, Tatarano S, Kinoshita T, Fuse M, Kojima S, Nakagawa M, Seki N.
    J Hum Genet; 2013 Aug 03; 58(8):508-16. PubMed ID: 23635949
    [Abstract] [Full Text] [Related]

  • 11. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
    Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H, Hartmann A, Seliger B.
    Sci Rep; 2020 Apr 16; 10(1):6499. PubMed ID: 32300145
    [Abstract] [Full Text] [Related]

  • 12. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W.
    Theranostics; 2020 Apr 16; 10(23):10791-10807. PubMed ID: 32929380
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H, Xu WH, Ren F, Wang J, Wang HK, Cao DL, Shi GH, Qu YY, Zhang HL, Ye DW.
    Aging (Albany NY); 2020 Jan 08; 12(1):866-883. PubMed ID: 31915310
    [Abstract] [Full Text] [Related]

  • 14. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.
    Ann Surg Oncol; 2014 Mar 08; 21(3):1046-54. PubMed ID: 24242678
    [Abstract] [Full Text] [Related]

  • 15. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X.
    Oncol Rep; 2013 Aug 08; 30(2):643-50. PubMed ID: 23754305
    [Abstract] [Full Text] [Related]

  • 16. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM.
    Carcinogenesis; 2013 Oct 08; 34(10):2231-9. PubMed ID: 23715501
    [Abstract] [Full Text] [Related]

  • 17. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B.
    Eur J Cancer; 2014 Jul 08; 50(10):1758-1765. PubMed ID: 24793999
    [Abstract] [Full Text] [Related]

  • 18. miR-4429 Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting CDK6 in Clear Cell Renal Cell Carcinoma.
    Pan H, Hong Y, Yu B, Li L, Zhang X.
    Cancer Biother Radiopharm; 2019 Jun 08; 34(5):334-341. PubMed ID: 30844301
    [Abstract] [Full Text] [Related]

  • 19. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.
    Khella HW, Scorilas A, Mozes R, Mirham L, Lianidou E, Krylov SN, Lee JY, Ordon M, Stewart R, Jewett MA, Yousef GM.
    Am J Pathol; 2015 Mar 08; 185(3):693-703. PubMed ID: 25572155
    [Abstract] [Full Text] [Related]

  • 20. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X, Quan J, Li Z, Zhao L, Zhou L, Jinling X, Weijie X, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Biomed Pharmacother; 2018 Jun 08; 102():718-727. PubMed ID: 29604591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.